BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 40.80B
Enterprise value 42.37B
Trailing P/E 13.15
Forward P/E 18.25
PEG ratio (5-yr expected) 3.24
Price/sales (ttm)4.06
Price/book (mrq)2.96
Enterprise value/revenue 4.19
Enterprise value/EBITDA 9.60

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 349.33%
S&P500 52-week change 31.77%
52-week high 3319.74
52-week low 3188.54
50-day moving average 3292.21
200-day moving average 3270.96

Share statistics

Avg vol (3-month) 3907.8k
Avg vol (10-day) 3705.71k
Shares outstanding 5144.74M
Implied shares outstanding 6N/A
Float 8144.32M
% held by insiders 10.69%
% held by institutions 189.90%
Shares short (14 May 2023) 42.96M
Short ratio (14 May 2023) 42.62
Short % of float (14 May 2023) 42.31%
Short % of shares outstanding (14 May 2023) 42.05%
Shares short (prior month 13 Apr 2023) 42M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin 30.99%
Operating margin (ttm)28.60%

Management effectiveness

Return on assets (ttm)7.49%
Return on equity (ttm)25.04%

Income statement

Revenue (ttm)10.1B
Revenue per share (ttm)69.87
Quarterly revenue growth (yoy)-2.70%
Gross profit (ttm)7.9B
EBITDA 3.38B
Net income avi to common (ttm)3.13B
Diluted EPS (ttm)21.16
Quarterly earnings growth (yoy)27.70%

Balance sheet

Total cash (mrq)5.04B
Total cash per share (mrq)34.83
Total debt (mrq)6.61B
Total debt/equity (mrq)47.94
Current ratio (mrq)3.24
Book value per share (mrq)95.28

Cash flow statement

Operating cash flow (ttm)1.68B
Levered free cash flow (ttm)1.67B